Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul 19:14:2191-2200.
doi: 10.2147/JPR.S301447. eCollection 2021.

Beta-Endorphin as a Biomarker in the Treatment of Chronic Pain with Non-Invasive Brain Stimulation: A Systematic Scoping Review

Erickson Bonifácio de Assis  1 , Carolina Dias de Carvalho  1 , Clarice Martins  1 , Suellen Andrade  1
Affiliations

Beta-Endorphin as a Biomarker in the Treatment of Chronic Pain with Non-Invasive Brain Stimulation: A Systematic Scoping Review

Erickson Bonifácio de Assis et al. J Pain Res. .

Abstract

A scoping review to synthesize evidence and assess articles describing the use of beta-endorphins as a pain biomarker in chronic pain patients treated with non-invasive brain stimulation techniques was systematically performed with respect to the study quality, the technique employed and the results. Independent reviewers determined if the article met the study criteria at each stage for it to be included. Content analysis was applied and summarized. The results are described in a narrative form grouped by pain condition, type of intervention, stimulation protocol, outcome measures and main results. A total of 67 of 73 references were excluded, and 6 identified studies met the inclusion criteria. The study design, sample size, stimulation type, session protocol and the main findings of each study were extracted. The studies in this scoping review ranged from unsatisfactory to good based on the adopted criteria, with no study achieving an excellent rating. There is limited evidence on the dosage of beta-endorphin in chronic pain conditions during treatment with NIBS. Based on this literature, evidence suggests that BE may not only be useful for acute and persistent pain, but also for a variety of chronic pain states in which opioids are not effective.

Keywords: chronic pain; electric stimulation; endorphin; review.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to report for this work.

Figures

Figure 1
Figure 1
Flow diagram for study selection.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Galhardoni R, Correia GS, Araujo H, et al. Repetitive transcranial magnetic stimulation in chronic pain: a review of the literature. Arch Phys Med Rehabil. 2015;96(4):S156–S172. doi:10.1016/j.apmr.2014.11.010 - DOI - PubMed
    1. Baptista AF, Fernandes AMBL, Sá KN, et al. Latin American and Caribbean consensus on noninvasive central nervous system neuromodulation for chronic pain management (LAC2-NIN-CP). Pain Rep. 2019;4(1):e692. doi:10.1097/PR9.0000000000000692 - DOI - PMC - PubMed
    1. Fishman MA, Antony A, Esposito M, Deer T, Levy R. The evolution of neuromodulation in the treatment of chronic pain: forward-looking perspectives. Pain Med. 2019;20(Supplement_1):S58–S68. doi:10.1093/pm/pnz074 - DOI - PMC - PubMed
    1. Lefaucheur J-P, André-Obadia N, Antal A, et al. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS). Clin Neurophysiol. 2014;125(11):2150–2206. - PubMed
    1. Lefaucheur J-P, Antal A, Ayache SS, et al. Evidence-based guidelines on the therapeutic use of transcranial direct current stimulation (tDCS). Clin Neurophysiol. 2017;128(1):56–92. - PubMed

Publication types